Offer - Urjas Oil for just ₹ 1 X
Glibenclamide (Glyburide) + Metformin + Pioglitazone is an allopathic medicine The correct dosage of Glibenclamide (Glyburide) + Metformin + Pioglitazone depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Glibenclamide (Glyburide) + Metformin + Pioglitazone is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Glibenclamide (Glyburide) + Metformin + Pioglitazone is used -
Severe
Moderate
Mild
Common
Is the use of Glibenclamide (Glyburide) + Metformin + Pioglitazone safe for pregnant women?
Glibenclamide (Glyburide) + Metformin + Pioglitazone can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Glibenclamide (Glyburide) + Metformin + Pioglitazone right away. Take your doctor's advice before taking it again.
Is the use of Glibenclamide (Glyburide) + Metformin + Pioglitazone safe during breastfeeding?
Breastfeeding women may feel side effects of Glibenclamide (Glyburide) + Metformin + Pioglitazone. If you see any side effects, stop taking Glibenclamide (Glyburide) + Metformin + Pioglitazone immediately and talk to your doctor. Take Glibenclamide (Glyburide) + Metformin + Pioglitazone again, only after your doctor's advice.
What is the effect of Glibenclamide (Glyburide) + Metformin + Pioglitazone on the Kidneys?
Glibenclamide (Glyburide) + Metformin + Pioglitazone may have mild side effects on the kidneys.
What is the effect of Glibenclamide (Glyburide) + Metformin + Pioglitazone on the Liver?
Glibenclamide (Glyburide) + Metformin + Pioglitazone can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Glibenclamide (Glyburide) + Metformin + Pioglitazone on the Heart?
Glibenclamide (Glyburide) + Metformin + Pioglitazone may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Glibenclamide (Glyburide) + Metformin + Pioglitazone should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glibenclamide (Glyburide) + Metformin + Pioglitazone unless your doctor advises you to do so -
Is this Glibenclamide (Glyburide) + Metformin + Pioglitazone habit forming or addictive?
No, you will not get addicted to Glibenclamide (Glyburide) + Metformin + Pioglitazone.
Interaction between Food and Glibenclamide (Glyburide) + Metformin + Pioglitazone
Information is not available on the interaction of any foods with Glibenclamide (Glyburide) + Metformin + Pioglitazone, due to a lack of research on this.
Interaction between Alcohol and Glibenclamide (Glyburide) + Metformin + Pioglitazone
Drinking alcohol while taking Glibenclamide (Glyburide) + Metformin + Pioglitazone may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033